Statistics

Total Visits

Views
Sorafenib (SOR) in advanced non-small cell lung cancer (NSCLC): A phase II study of patient progress after several lines of treatment45

Select a period of time:

Number of views in the range

Views
Sorafenib (SOR) in advanced non-small cell lung cancer (NSCLC): A phase II study of patient progress after several lines of treatment18

Views

Views
October 20243
November 20241
December 20241
January 20250
February 20250
March 202513
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore13
Canada1
United Kingdom1
 

Top cities views

Views
Toronto1